Get an alert when BENEVOLENTAI BIO LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£9k

-92.7% lowest in 3 filed years

Net assets

-£63m

+8% vs 2024

Employees

8

-86% lowest in 3 filed years

Profit before tax

£5.5m

+132.8% highest in 3 filed years

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31

Metric Trend 2023-12-312024-12-312025-12-31 Δ vs prior
Turnover £8,741,000£6,468,000£8,890,000 +37.4%
Operating profit -£21,927,000-£16,776,000£5,495,000 +132.8%
Profit before tax -£21,927,000-£16,777,000£5,495,000 +132.8%
Net profit -£18,370,000-£14,149,000£5,495,000 +138.8%
Cash £258,000£123,000£9,000 -92.7%
Total assets less current liabilities -£57,621,000-£68,907,000-£63,403,000 +8%
Net assets -£55,765,000-£68,914,000-£63,403,000 +8%
Equity ——— —
Average employees 101578 -86%
Wages £8,601,000£4,792,000£364,000 -92.4%
Directors' remuneration £366,000£435,000£92,000 -78.9%
Directors' pension contributions £2,000£2,000£0 -100%
Highest paid director £366,000£435,000£92,000 -78.9%

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-312025-12-31
Operating margin ——61.8%
Net margin ——61.8%
Gearing (liabilities / total assets) 498.1%924.0%45387.9%
Current ratio 0.17x0.11x0.00x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

Name history

Renamed 1 time since incorporation

  1. BENEVOLENTAI BIO LIMITED 2016-08-25 → present
  2. STRATIFIED MEDICAL LIMITED 2013-11-13 → 2016-08-25

Audit & accounting basis

Accounting basis
IFRS
Reporting scope
Standalone (parent only)
Auditor
Cooper Parry Group Limited
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Company is currently dependent on financing being made available by BenevolentAI Limited to enable it to continue operating and to meet its liabilities. After reviewing Group-wide and Company cash flow forecasts and business plans, the Directors have a reasonable expectation...”

Group structure

  1. BENEVOLENTAI BIO LIMITED · parent
    1. Stratified Medical Limited 100% · United Kingdom · Dormant

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 8 resigned

Name Role Appointed Born Nationality
HUNTER, James Director 2026-03-20 Jan 1967 British
MULVANY, Kenneth Patrick Director 2026-03-10 Jan 1968 British
Show 8 resigned officers
Name Role Appointed Resigned
REED SMITH CORPORATE SERVICES LIMITED Corporate Secretary 2013-11-13 2013-11-21
BRENNAN, Michael James Director 2025-01-14 2026-03-19
GRIFFIN, Ivan Director 2019-05-29 2026-03-25
HOLGATE, Tom Joseph Charles Director 2019-05-29 2025-02-07
HUNTER, Ann Jacqueline, Professor Director 2016-03-23 2021-03-08
MULVANY, Kenneth Patrick Director 2013-11-13 2019-05-29
PHELAN, Anne Director 2019-05-29 2024-12-11
SHIELDS, Joanna Director 2019-05-29 2023-09-21

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Benevolentai Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2018-01-01 Active
Super secure — Ceased 2018-01-01

Filing timeline

Last 20 of 72 total filings

Date Type Category Description
2026-09-07 AA accounts Accounts with accounts type full
2026-06-22 CS01 confirmation-statement Confirmation statement with no updates PDF
2026-04-01 TM01 officers Termination director company with name termination date PDF
2026-03-25 AP01 officers Appoint person director company with name date PDF
2026-03-23 TM01 officers Termination director company with name termination date PDF
2026-03-12 AP01 officers Appoint person director company with name date PDF
2025-10-07 CH01 officers Change person director company with change date PDF
2025-10-02 AA accounts Accounts with accounts type full
2025-06-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-02-07 TM01 officers Termination director company with name termination date PDF
2025-01-16 AP01 officers Appoint person director company with name date PDF
2024-12-11 TM01 officers Termination director company with name termination date PDF
2024-10-01 AA accounts Accounts with accounts type full
2024-06-21 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-10-04 TM01 officers Termination director company with name termination date PDF
2023-09-29 AA accounts Accounts with accounts type full
2023-06-28 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-07-04 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-06-14 AA accounts Accounts with accounts type full
2021-09-13 AA accounts Accounts with accounts type full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
8

last 12 months

Capital events
0

last 24 months

Officers appointed
2

last 12 months

Officers resigned
2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page